Trainings to generate genetically modified models in specific organisms will be provided on different sites according the speciality:
zebrafish model at AMAGEN (Gif - s - Yvette), rat model at the TRIP (Nantes) and mouse model at Anexplo (Toulouse).
Not exact matches
«We knew that the brain hat was a very high potential» among marchers, says Chris Pierret, a biologist
at the Mayo Clinic in Rochester, but his group commissioned crocheted
zebrafish hats, honoring one of their favorite disease research
models.
Research in the laboratory of Rebecca Wingert, the Gallagher Family Associate Professor of Adult Stem Cell Research in the Department of Biological Sciences
at the University of Notre Dame, has confirmed the key role of a certain small molecule in the development of kidney structures in
zebrafish, a widely used
model for human kidneys.
To test whether fatty acid levels in the bloodstream was a cause or a consequence of disease, the researchers turned to a
zebrafish model of Crohn's disease that had been developed by Stefan Oehlers, a post-doctoral fellow in David Tobin's group
at Duke.
His group studies the cellular and genetic control of gastrulation movements in
zebrafish, one of the
model organisms studied
at the institute besides Drosophila, the C. elegans worm, frogs, mice, and newts.
«We use
zebrafish to study Alagille syndrome because these vertebrates allow us to use experimental approaches that aren't possible with other disease
models,» says Duc Dong, Ph.D., assistant professor in the Human Genetics Program
at SBP and senior author of the paper.
At the Erasmus Medical Center in Rotterdam, the Netherlands, researchers have investigated this movement disorder using a PARK15 (an atypical early - onset parkinsonism)
zebrafish model and DanioVision.
Before coming to Columbia she worked as a technician in Leonard Zon's lab
at Harvard Medical School using
zebrafish as a
model for investigating the molecular mechanisms of hematopoietic stem cell differentiation and self renewal.
Dr. Falk is also PI of an NIH, pharma, and philanthropic funded translational research laboratory group
at CHOP that investigates the causes and global metabolic consequences of mitochondrial disease, as well as targeted therapies, in C. elegans,
zebrafish, mouse, and human tissue
models of genetic - based respiratory chain dysfunction, and directs multiple clinical treatment trials in mitochondrial disease patients.